Reversible Myocardial Dysfunction in the Critically Ill

  • Research type

    Research Study

  • Full title

    Evaluation of the time course of acute, reversible myocardial dysfunction in the general adult intensive care population

  • IRAS ID

    134971

  • Contact name

    Victoria Trubody

  • Contact email

    victoria.trubody@ndcn.ox.ac.uk

  • Research summary

    This study aims to describe the time course of reversible heart function in patients experiencing critical illness. It is
    known that a reversible heart impairment can occur in patients with certain types of critical illness, such as severe
    infections. Little is known about how this condition may affect other types of patients admitted to Intensive Care, or if the
    results seen in patients with infections are applicable to other groups.
    We wish to use both ultrasound (echocardiography) and cardiac magnetic resonance imaging (CMRI) to look at in
    detail any changes in, and the recovery of, heart function during critical illness. Whilst participants are admitted to the
    Intensive Care Unit, we wish to assess changes in heart function using bedside echocardiography. When some of
    these participants have been discharged to the wards, and are medically stable, we wish to use CMRI to add further,
    highly detailed, information about the recovery of the heart following critical illness.
    Finally, in participants who demonstrate impaired heart function whilst in hospital and who are not receiving certain
    heart medications (e.g. noradrenaline), we wish to take a small blood sample at the time of heart assessments to see
    if the reversible heart impairment seen in critically ill patients share common features with other reversible heart
    conditions (elevated stress hormones).
    This study will assess the changes in heart function during the course of, and recovery from, critical illness. We wish to
    study a total of 60 patients over the next year. The study will be conducted at Oxford University Hospitals NHS Trust,
    funded by the Nuffield Department of Clinical Neurosciences, University of Oxford.

  • REC name

    South Central - Berkshire Research Ethics Committee

  • REC reference

    14/SC/0305

  • Date of REC Opinion

    26 Jun 2014

  • REC opinion

    Favourable Opinion